BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
May 03, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

IPI-926: Phase Ib/II started

Infinity began an international Phase Ib/II trial to evaluate IPI-926 in combination with gemcitabine. The dose-escalating Phase Ib portion will evaluate oral IPI-926 given once daily plus IV gemcitabine in an undisclosed...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >